Surgical Science Sweden AB (publ) (SUS.ST)

SEK 154.5

(0.85%)

Operating Expenses Summary of Surgical Science Sweden AB (publ)

Surgical Science Sweden AB (publ)'s latest annual operating expenses in 2023 was 367.6 Million SEK , down -0.37% from previous year.
Surgical Science Sweden AB (publ)'s latest quarterly operating expenses in 2024 Q2 was 98.19 Million SEK , up 26.69% from previous quarter.
Surgical Science Sweden AB (publ) reported a annual operating expenses of 368.98 Million SEK in annual operating expenses 2022, up 76.19% from previous year.
Surgical Science Sweden AB (publ) reported a annual operating expenses of 209.41 Million SEK in annual operating expenses 2021, up 206.21% from previous year.
Surgical Science Sweden AB (publ) reported a quarterly operating expenses of 98.19 Million SEK for 2024 Q2, up 26.69% from previous quarter.
Surgical Science Sweden AB (publ) reported a quarterly operating expenses of 94.33 Million SEK for 2023 Q3, down -4.91% from previous quarter.

Annual Operating Expenses Chart of Surgical Science Sweden AB (publ) (2023 - 2014)

Historical Annual Operating Expenses of Surgical Science Sweden AB (publ) (2023 - 2014)

Year	Operating Expenses	Operating Expenses Growth
2023	367.6 Million SEK	-0.37%
2022	368.98 Million SEK	76.19%
2021	209.41 Million SEK	206.21%
2020	68.39 Million SEK	-0.02%
2019	68.4 Million SEK	-9.98%
2018	75.98 Million SEK	15.39%
2017	65.85 Million SEK	12.76%
2016	58.4 Million SEK	15.19%
2015	50.7 Million SEK	95.91%
2014	25.87 Million SEK	0.0%

Year	Operating Expenses	Operating Expenses Growth
2024 Q1	86.87 Million SEK	-8.43%
2024 Q2	98.19 Million SEK	26.69%
2023 Q3	94.33 Million SEK	-4.91%
2023 FY	367.6 Million SEK	-0.37%
2023 Q1	105.41 Million SEK	2.32%
2023 Q2	99.2 Million SEK	-5.9%
2023 Q4	94.87 Million SEK	0.57%
2022 Q1	82.75 Million SEK	-7.91%
2022 FY	368.98 Million SEK	76.19%
2022 Q4	103.03 Million SEK	8.88%
2022 Q3	94.62 Million SEK	6.84%
2022 Q2	88.56 Million SEK	7.03%
2021 Q2	29.3 Million SEK	1.31%
2021 Q1	28.92 Million SEK	45.46%
2021 FY	209.41 Million SEK	206.21%
2021 Q4	89.86 Million SEK	46.5%
2021 Q3	61.33 Million SEK	109.34%
2020 Q1	17.26 Million SEK	-15.89%
2020 Q3	14.21 Million SEK	-16.55%
2020 Q4	19.88 Million SEK	39.92%
2020 FY	68.39 Million SEK	-0.02%
2020 Q2	17.02 Million SEK	-1.39%
2019 Q1	15.45 Million SEK	-34.18%
2019 FY	68.4 Million SEK	-9.98%
2019 Q3	18.53 Million SEK	33.62%
2019 Q4	20.53 Million SEK	10.76%
2019 Q2	13.87 Million SEK	-10.25%
2018 Q2	18.6 Million SEK	5.08%
2018 FY	75.98 Million SEK	15.39%
2018 Q3	16.2 Million SEK	-12.9%
2018 Q4	23.48 Million SEK	44.99%
2018 Q1	17.7 Million SEK	-20.82%
2017 Q4	22.35 Million SEK	53.11%
2017 Q1	13.3 Million SEK	-34.8%
2017 FY	65.85 Million SEK	12.76%
2017 Q2	15.6 Million SEK	17.29%
2017 Q3	14.6 Million SEK	-6.41%
2016 Q2	14.3 Million SEK	9.16%
2016 Q1	13.1 Million SEK	0.0%
2016 Q3	10.6 Million SEK	-25.87%
2016 FY	58.4 Million SEK	15.19%
2016 Q4	20.4 Million SEK	92.45%
2015 FY	50.7 Million SEK	95.91%
2014 FY	25.87 Million SEK	0.0%

Peer Operating Expenses Comparison of Surgical Science Sweden AB (publ)

Name	Operating Expenses	Operating Expenses Difference
Aino Health AB (publ)	13.31 Million SEK	-2661.626%
Bonzun AB (publ)	5.00 SEK	-7351999900.0%
Kontigo Care AB (publ)	43.23 Million SEK	-750.316%
Medhelp Care Aktiebolag (publ)	100.87 Million SEK	-264.426%
RaySearch Laboratories AB (publ)	800.7 Million SEK	54.09%